{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:44:04Z","timestamp":1777880644087,"version":"3.51.4"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,25]]},"DOI":"10.18632\/oncotarget.11499","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T23:08:02Z","timestamp":1471907282000},"page":"69871-69882","source":"Crossref","is-referenced-by-count":17,"title":["Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface"],"prefix":"10.18632","volume":"7","author":[{"given":"Subbulakshmi","family":"Karthikeyan","sequence":"first","affiliation":[{"name":"Center for Biomolecular Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel D.","family":"Lantvit","sequence":"additional","affiliation":[{"name":"Center for Biomolecular Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dam Hee","family":"Chae","sequence":"additional","affiliation":[{"name":"Center for Biomolecular Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna E.","family":"Burdette","sequence":"additional","affiliation":[{"name":"Center for Biomolecular Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"1","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Jemal","year":"2016","journal-title":"CA"},{"key":"2","first-page":"932371","article-title":"Ovarian cancer pathogenesis: a model in evolution","volume":"2010","author":"Drapkin","year":"2010","journal-title":"Journal of oncology"},{"key":"3","first-page":"22","article-title":"The new face of ovarian cancer modeling: better prospects for detection and treatment","volume":"3","author":"Drapkin","year":"2011","journal-title":"F1000 medicine reports"},{"key":"4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Kurman","year":"2013","journal-title":"Histopathology"},{"key":"5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Verheijen","year":"2001","journal-title":"The Journal of pathology"},{"key":"6","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Lu","year":"2005","journal-title":"Clinical cancer research"},{"key":"7","doi-asserted-by":"crossref","first-page":"e80314","DOI":"10.1371\/journal.pone.0080314","article-title":"Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes","volume":"8","author":"Ince","year":"2013","journal-title":"PloS one"},{"key":"8","first-page":"107","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","author":"Altman","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Drapkin","year":"2013","journal-title":"Cancer cell"},{"key":"10","first-page":"3","article-title":"Modeling high-grade serous carcinoma: how converging insights into pathogenesis and genetics are driving better experimental platforms","author":"Drapkin","year":"2013","journal-title":"Frontiers in oncology"},{"key":"11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1101\/gad.190678.112","article-title":"Mutant p53: one name, many proteins","volume":"26","author":"Prives","year":"2012","journal-title":"Genes & development"},{"key":"12","doi-asserted-by":"crossref","first-page":"19257","DOI":"10.3390\/ijms140919257","article-title":"The consequence of oncomorphic TP53 mutations in ovarian cancer","volume":"14","author":"Leslie","year":"2013","journal-title":"International journal of molecular sciences"},{"key":"13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","article-title":"Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome","volume":"119","author":"Jacks","year":"2004","journal-title":"Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ncb1571","article-title":"p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM","volume":"9","author":"Xu","year":"2007","journal-title":"Nature cell biology"},{"key":"15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2015.04.039","article-title":"TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas","volume":"138","author":"Shahabi","year":"2015","journal-title":"Gynecologic oncology"},{"key":"16","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1158\/0008-5472.CAN-13-1079","article-title":"Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53","volume":"75","author":"El-Deiry","year":"2015","journal-title":"Cancer research"},{"key":"17","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.29528","article-title":"Mutant p53 expression in fallopian tube epithelium drives cell migration","volume":"137","author":"Burdette","year":"2015","journal-title":"International journal of cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"e40378","DOI":"10.1371\/journal.pone.0040378","article-title":"The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion","volume":"7","author":"Tartare-Deckert","year":"2012","journal-title":"PloS one"},{"key":"19","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Sampaio","year":"2001","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"20","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.onc.1210280","article-title":"p53 alterations in human cancer: more questions than answers","volume":"26","author":"Soussi","year":"2007","journal-title":"Oncogene"},{"key":"21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygyno.2007.05.009","article-title":"Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer","volume":"106","author":"Langdon","year":"2007","journal-title":"Gynecologic oncology"},{"key":"22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.rbmo.2013.06.013","article-title":"The human oviduct transcriptome reveals an anti-inflammatory, anti-angiogenic, secretory and matrix-stable environment during embryo transit","volume":"27","author":"Giudice","year":"2013","journal-title":"Reproductive biomedicine online"},{"key":"23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1158\/1535-7163.MCT-14-0880","article-title":"A novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgrafts","volume":"14","author":"Conover","year":"2015","journal-title":"Molecular cancer therapeutics"},{"key":"24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.3185","article-title":"Identification of six new susceptibility loci for invasive epithelial ovarian cancer","volume":"47","author":"Coetzee","year":"2015","journal-title":"Nature genetics"},{"key":"25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/OTT.S32918","article-title":"Recombinant human decorin suppresses liver HepG2 carcinoma cells by p21 upregulation","volume":"5","author":"Zhang","year":"2012","journal-title":"OncoTargets and therapy"},{"key":"26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1476-4598-9-82","article-title":"Regulation of MCP-1 chemokine transcription by p53","volume":"9","author":"Rosl","year":"2010","journal-title":"Molecular cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1158\/0008-5472.CAN-11-0640","article-title":"FoxM1: a master regulator of tumor metastasis","volume":"71","author":"Park","year":"2011","journal-title":"Cancer research"},{"key":"28","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/oncsis.2013.15","article-title":"More targets, more pathways and more clues for mutant p53","volume":"2","author":"Landi","year":"2013","journal-title":"Oncogenesis"},{"key":"29","first-page":"3035","article-title":"Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers","volume":"14","author":"Becker","year":"2009","journal-title":"Frontiers in bioscience"},{"key":"30","doi-asserted-by":"crossref","first-page":"e72162","DOI":"10.1371\/journal.pone.0072162","article-title":"Type-specific cell line models for type-specific ovarian cancer research","volume":"8","author":"Huntsman","year":"2013","journal-title":"PloS one"},{"key":"31","first-page":"21","article-title":"The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice","author":"Matzuk","year":"2015","journal-title":"Clinical Cancer Research"},{"key":"32","doi-asserted-by":"publisher","first-page":"18641","DOI":"10.18632\/oncotarget.4080","article-title":"Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers","volume":"6","author":"Shahabi","year":"2015","journal-title":"Oncotarget"},{"key":"33","first-page":"pl1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Schultz","year":"2013","journal-title":"Sci Signal"},{"key":"34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Schultz","year":"2012","journal-title":"Cancer Discov"},{"key":"35","doi-asserted-by":"publisher","first-page":"41929","DOI":"10.18632\/oncotarget.9740","article-title":"Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma","volume":"7","author":"Zannini","year":"2016","journal-title":"Oncotarget"},{"key":"36","doi-asserted-by":"crossref","first-page":"e44869","DOI":"10.1371\/journal.pone.0044869","article-title":"A p53-Pax2 pathway in kidney development: implications for nephrogenesis","volume":"7","author":"El-Dahr","year":"2012","journal-title":"PloS one"},{"key":"37","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact","volume":"26","author":"Drapkin","year":"2008","journal-title":"J Clin Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2004.11.006","article-title":"Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome","volume":"119","author":"Lozano","year":"2004","journal-title":"Cell"},{"key":"39","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1101\/gad.1662908","article-title":"The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss","volume":"22","author":"Lozano","year":"2008","journal-title":"Genes & development"},{"key":"40","doi-asserted-by":"publisher","first-page":"20500","DOI":"10.18632\/oncotarget.3985","article-title":"Tumorigenesis and peritoneal colonization from fallopian tube epithelium","volume":"6","author":"Burdette","year":"2015","journal-title":"Oncotarget"},{"key":"41","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1158\/1078-0432.CCR-06-2926","article-title":"Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer","volume":"13","author":"Hotz","year":"2007","journal-title":"Clinical cancer research"},{"key":"42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature15251","article-title":"Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth","volume":"525","author":"Berger","year":"2015","journal-title":"Nature"},{"key":"43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ccell.2015.12.002","article-title":"A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas","volume":"29","author":"Eisenberg","year":"2016","journal-title":"Cancer cell"},{"key":"44","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1126\/science.2144057","article-title":"Suppression of human colorectal carcinoma cell growth by wild-type p53","volume":"249","author":"Vogelstein","year":"1990","journal-title":"Science"},{"key":"45","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1039\/C3NR05042D","article-title":"Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells","volume":"6","author":"Burdette","year":"2014","journal-title":"Nanoscale"},{"key":"46","doi-asserted-by":"crossref","first-page":"e89553","DOI":"10.1371\/journal.pone.0089553","article-title":"Mutation or loss of p53 differentially modifies TGF\u03b2 action in ovarian cancer","volume":"9","author":"Burdette","year":"2014","journal-title":"PloS one"},{"key":"47","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2015.05.040","article-title":"In vivo tumor growth of high-grade serous ovarian cancer cell lines","volume":"138","author":"VB","year":"2015","journal-title":"Gynecologic oncology"},{"key":"48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/gene.20008","article-title":"Tissue-specific expression of cre recombinase from the Pax8 locus","volume":"38","author":"Busslinger","year":"2004","journal-title":"Genesis"},{"key":"49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/ERC-11-0107","article-title":"The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer","volume":"18","author":"Burdette","year":"2011","journal-title":"Endocrine-related cancer"},{"key":"50","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1158\/0008-5472.CAN-15-1582","article-title":"Nitric oxide regulates gene expression in cancers by controlling histone posttranslational modifications","volume":"75","author":"Garcia","year":"2015","journal-title":"Cancer research"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:34:08Z","timestamp":1589290448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":50,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2016,10,25]]}},"alternative-id":["11499","27563818"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11499","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]}}}